Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 19/20 | 0.84 |
| ▸ | SLC6A2 | P23975 | 16/20 | 0.84 |
| ▸ | SLC6A4 | P31645 | 11/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17043263 | 1.00 | SLC6A3 (0.84) | SLC6A3SLC6A2SLC6A4 | |
| Hydrochloric Acid SCHEMBL15163018 | 0.99 | SLC6A3 (0.82) | SLC6A3SLC6A2SLC6A4 | |
| Pyrovalerone SCHEMBL164376 | 0.91 | SLC6A3 (1.00) | SLC6A3SLC6A2SLC6A4 | |
| Pyrovalerone SCHEMBL4930605 | 0.91 | SLC6A3 (1.00) | SLC6A3SLC6A2SLC6A4 | |
| Pyrovalerone SCHEMBL4929129 | 0.91 | SLC6A3 (1.00) | SLC6A3SLC6A2SLC6A4 | |
| Pyrovalerone SCHEMBL121638 | 0.90 | SLC6A3 (0.97) | SLC6A3SLC6A2SLC6A4 | |
| Pyrovalerone SCHEMBL1649739 | 0.89 | SLC6A3 (0.94) | SLC6A3SLC6A2SLC6A4 | |
| SCHEMBL21271156 | 0.87 | SLC6A3 (0.83) | SLC6A3SLC6A2SLC6A4 | |
| SCHEMBL27098434 | 0.86 | SLC6A3 (0.81) | SLC6A3SLC6A2SLC6A4 | |
| SCHEMBL27098438 | 0.86 | SLC6A3 (0.81) | SLC6A3SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260086062-A1 | IMMOBILIZATION STRATEGIES FOR ENHANCING SENSITIVITY OF ELECTROCHEMICAL APTAMER-BASED SENSORS | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2026-03-26 | — | — | US | claimed |
| US-20230054132-A1 | DNA APTAMER-CYANINE COMPLEXES AS GENERIC COLORIMETRIC SENSORS | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2023-02-23 | — | — | US | claimed |
| US-11060095-B2 | Method for isolating cross-reactive aptamer and use thereof | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2021-07-13 | — | — | US | claimed |
| US-20210102210-A1 | METHOD FOR ISOLATING CROSS-REACTIVE APTAMER AND USE THEREOF | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2021-04-08 | — | — | US | claimed |
| US-10907162-B2 | Method for isolating cross-reactive aptamer and use thereof | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2021-02-02 | — | — | US | claimed |
| US-20200172907-A1 | METHOD FOR ISOLATING CROSS-REACTIVE APTAMER AND USE THEREOF | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2020-06-04 | — | — | US | claimed |
| US-10655132-B1 | Method for isolating cross-reactive aptamer and use thereof | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2020-05-19 | — | — | US | claimed |
| US-20200141958-A1 | MATERIAL AND METHOD FOR COLORIMETRIC DETECTION OF SMALL-MOLECULE TARGETS | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2020-05-07 | — | — | US | claimed |
| US-20200131514-A1 | METHOD FOR ISOLATING CROSS-REACTIVE APTAMER AND USE THEREOF | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2020-04-30 | — | — | US | claimed |
| EP-2626358-B1 | Immunoassay for pyrrolidinophenones | RANDOX LAB LTD (GB) | 2015-09-02 | — | — | EP | claimed |
| US-20130210167-A1 | IMMUNOASSAY FOR PYRROLIDINOPHENONES | RANDOX LABORATORIES LIMITED (GB) | 2013-08-15 | — | — | US | claimed |
| EP-2626358-A1 | Immunoassay for pyrrolidinophenones | Randox Laboratories Ltd. (GB) | 2013-08-14 | — | — | EP | claimed |
| US-20260086062-A1 | IMMOBILIZATION STRATEGIES FOR ENHANCING SENSITIVITY OF ELECTROCHEMICAL APTAMER-BASED SENSORS | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2026-03-26 | — | — | US | disclosed |
| US-12455256-B2 | Immobilization strategies for enhancing sensitivity of electrochemical aptamer-based sensors | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2025-10-28 | — | — | US | disclosed |
| US-20250186510-A1 | BACTERIAL COMPOSITION FOR USE IN TREATMENT OF SUBSTANCE USE DISORDER | BAR-ILAN UNIVERSITY (IL) | 2025-06-12 | — | — | US | disclosed |
| US-20240053291-A1 | IMMOBILIZATION STRATEGIES FOR ENHANCING SENSITIVITY OF ELECTROCHEMICAL APTAMER-BASED SENSORS | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2024-02-15 | — | — | US | disclosed |
| EP-2626358-A1 | Immunoassay for pyrrolidinophenones | Randox Laboratories Ltd. (GB) | 2013-08-14 | — | — | EP | disclosed |
| EP-1670755-A4 | PYROVALERONE ANALOGS AND THERAPEUTIC USES THEREOF | HARVARD COLLEGE (US) | 2007-02-28 | — | — | EP | disclosed |
| EP-1670755-A2 | PYROVALERONE ANALOGS AND THERAPEUTIC USES THEREOF | President And Fellows of Harvard College (US) | 2006-06-21 | — | — | EP | disclosed |
| WO-2005034878-A2 | PYROVALERONE ANALOGS AND THERAPEUTIC USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2005-04-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210102210-A1 | METHOD FOR ISOLATING CROSS-REACTIVE APTAMER AND USE THEREOF | SELE, ADAR, CDA | SLC6A3 391/4885SLC6A2 380/4885SLC6A4 1014/4885 |
| US-11060095-B2 | Method for isolating cross-reactive aptamer and use thereof | SELE, ADAR, CDA | SLC6A3 391/4885SLC6A2 380/4885SLC6A4 1014/4885 |
| US-10655132-B1 | Method for isolating cross-reactive aptamer and use thereof | SELE, ADAR, CDA | SLC6A3 306/4885SLC6A2 296/4885SLC6A4 867/4885 |
| US-10907162-B2 | Method for isolating cross-reactive aptamer and use thereof | SELE, ADAR, CDA | SLC6A3 290/4885SLC6A2 272/4885SLC6A4 767/4885 |
| US-20260086062-A1 | IMMOBILIZATION STRATEGIES FOR ENHANCING SENSITIVITY OF ELECTROCHEMICAL APTAMER-BASED SENSORS | EBPL, ADA, XBP1 | SLC6A3 186/4885SLC6A2 261/4885SLC6A4 1084/4885 |
| US-20200172907-A1 | METHOD FOR ISOLATING CROSS-REACTIVE APTAMER AND USE THEREOF | SELE, ADAR, CDA | SLC6A3 306/4885SLC6A2 296/4885SLC6A4 867/4885 |
| US-20200131514-A1 | METHOD FOR ISOLATING CROSS-REACTIVE APTAMER AND USE THEREOF | SELE, ADAR, CDA | SLC6A3 306/4885SLC6A2 296/4885SLC6A4 867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.